F 0602
Protect each resident from the wrongful use of the resident's belongings or money.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** THE
FOLLOWING DEFICIENCY REPRESENTS AN INCIDENT OF PAST NON-COMPLIANCE THAT WAS
SUBSEQUENTLY CORRECTED PRIOR TO THIS SURVEY.
Residents Affected - Some
Based on medical record review, staff interview, facility investigation, self-reported incident (SRI) review,
policy and procedure for Abuse, Neglect and Exploitation and, policy and procedure for Inventory Control of
Controlled Substances review, the facility failed to ensure controlled medication was not misappropriated.
This affected six (Residents #1, #2, #3, #4, #5, and #6) out of 41 residents that resided in the facility at the
time of misappropriation.
Findings include:
Review of SRI tracking number 254526 dated 11/27/24, medical records, and facility investigation revealed
controlled medications for Residents #1, #2, #3, #4, #5, and #6 had been misappropriated by Registered
Nurse (RN) #103. The morning of 11/27/24, Licensed Practical Nurse (LPN) #101 completed the narcotic
count with an agency RN #103. The count was correct. LPN #101 was administering medication and
noticed some concerns with the documentation the narcotic accountability records. LPN #101 notified the
Director of Nursing (DON). The DON initiated an investigation. The DON audited the narcotic accountability
records and found signatures that did not match the facility staff. The DON cross referenced the
medications on the narcotic accountability record and the medication administration record (MAR). The
DON found the following discrepancies:
1. Review of the medical record revealed Resident #1 was admitted on [DATE] with diagnoses that included
type two diabetes, anxiety disorder, acute and chronic respiratory failure with hypoxia, history of transient
ischemic attack, and pain. The quarterly Minimum Data Set (MDS) assessment dated [DATE] revealed
Resident #1 was cognitively intact and received opioid medication.
Resident #1 was ordered Oxycodone (opioid for severe pain) five milligrams (mg) twice a day as needed.
Review of the narcotic accountability record revealed an unrecognized signature on 11/26/24 at 3:00 A.M.
and 3:30 P.M. The MAR did not reveal documentation of Oxycodone being administered to Resident #1.
2. Review of the medical record revealed Resident #2 was admitted on [DATE] and readmitted [DATE] with
diagnoses that included Alzheimer's disease, acute respiratory failure, epilepsy, carcinoma of breast,
ulcerative colitis, fibromyalgia, irritable bowel, pain in left shoulder, bilateral knees and right hip. The
quarterly MDS assessment dated [DATE] revealed Resident #2 was cognitively impaired and received
antianxiety medication.
Resident #2 was ordered clonazepam (benzodiazepine) one mg three times a day at 5:00 A.M., 1:00
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 5
Event ID:
366253
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366253
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/20/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Amberwood Manor
245 South Broadway
New Philadelphia, OH 44663
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0602
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
P.M. and 9:00 P.M. The narcotic accountability record revealed clonazepam was signed out on 11/20/24 at
8:00 A.M. with an unrecognizable signature. The MAR did not reveal documentation of clonazepam being
administered to Resident #2 on 11/20/24 at 8:00 A.M.
3. Review of the medical record revealed Resident #3 was admitted on [DATE] with diagnoses that included
vesicointestinal fistula, chronic kidney disease, pelvic and perineal pain, and acute ischemia of large
intestine. The quarterly MDS assessment dated [DATE] revealed Resident #3 was cognitively intact and
received opioid medication.
Resident #3 was ordered Norco (opioid to treat moderate pain) 10-325 mg three times a day as needed.
The narcotic accountability record revealed Norco on 11/26/24 at 6:10 A.M. and 2:00 P.M. were signed out
and administered by facility nurses. Further review of the narcotic accountability record revealed after the
2:00 P.M. signature on 11/26/24, unrecognizable signatures signed out Norco on 11/25/24 at 8:00 A.M. and
11/26/24 at 1:00 P.M. The MAR did not reveal documentation of Norco being administered on 11/25/24 at
8:00 A.M. and 11/26/24 at 1:00 P.M.
4. Review of the medical record revealed Resident #4 was admitted [DATE] and discharged [DATE] with
diagnoses of abscess of right lower limb, Stage II (partial-thickness skin loss involving the epidermis and
dermis) pressure ulcer, lymphedema, and cellulitis. The MDS assessment dated [DATE] revealed Resident
#4 had cognitive impairment and received antianxiety and opioid medication.
Resident #4 was ordered Percocet (opioid for moderate to severe pain) 5-325 mg every eight hours as
needed. A medication card with seven Percocet 5-325 mg arrived at the facility on 11/20/24. Facility nurses
administered Percocet on 11/21/24 at 7:33 A.M. and 11/22/24 at 3:25 A.M. The card with the remaining five
Percocet and the shift change control count sheet were discovered missing during the investigation. A
second medication card of Percocet arrived at the facility on 11/22/24. The narcotic accountability record
revealed unrecognizable signatures signed out Percocet on 11/17/24 at 7:15 A.M., 11/18/24 at 10:10 A.M.,
11/19/24 at 7:43 P.M., 11/21/24 at 8:35 A.M., 11/21/24 at 8:30 P.M., and 11/22/24 at 8:30 P.M. The MAR did
not reveal documentation of Percocet being administered. Resident #4 was not admitted until 11/19/24 and
the medication card was not delivered until 11/22/24.
5. Review of the medical record revealed Resident #5 was admitted on [DATE] and readmitted on [DATE]
with diagnoses of multiple rib fractures, chronic respiratory failure, anxiety disorder, dementia, sacroiliitis,
and spinal stenosis. The MDS assessment dated [DATE] revealed Resident #5 had cognitive impairment
and received opioid, antipsychotic, and antianxiety medications.
Resident #5 was ordered tramadol (controlled medication for moderate to moderately severe pain) 50 mg
three times a day as needed. The narcotic accountability record revealed an unrecognizable signature
signed out tramadol on 11/26/24 at 1:00 P.M. The MAR did not reveal tramadol was administered.
6. Review of the medical record revealed Resident #6 was admitted on [DATE] and discharged [DATE] with
diagnoses that included fracture of right femur, type two diabetes, and acute pain due to trauma. The MDS
assessment dated [DATE] revealed Resident #6 was cognitively intact and received antianxiety, hypnotic,
and opioid medication.
Resident #6 was ordered tramadol 50 mg every six hours as needed. RN #103 signed the narcotic
accountability record on 11/27/24 at 5:00 A.M. The MAR did not reveal tramadol was administered.
Interview on 12/20/24 at 10:06 A.M. LPN #101 revealed they discovered the possible drug diversion
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366253
If continuation sheet
Page 2 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366253
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/20/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Amberwood Manor
245 South Broadway
New Philadelphia, OH 44663
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0602
Level of Harm - Minimal harm
or potential for actual harm
and immediately notified the DON. LPN #101 stated they looked at the cards of medication while RN #103
looked at the narcotic accountability record. LPN #101 stated the drug count was correct. LPN #101 noticed
unknown signatures on controlled medications and medications being administered at unusual times. LPN
#101 stated she now looked at the book and the cards of medication prior to her shift for any unusual
activity and to make sure the count was correct.
Residents Affected - Some
Interview on 12/20/24 at 1:45 P.M. the DON verified the attending physicians, medical director, board of
nursing, pharmacy board, drug enforcement agency, local police, and agency company were notified of the
potential drug diversion. RN #103 did not respond to phone calls or text messages. The agency reported
RN #103 did not respond to any of their calls. RN #103's demographic information was requested from the
agency company. The facility discovered RN #103 had previous nursing board probationary actions against
his nursing license that were lifted in 2021 due to theft charges and possession of marijuana charges from
2007 and 2009. The DON also verified Resident #1 had two Oxycodone that were unaccounted for.
Resident #2 had one clonazepam unaccounted for. Resident #3 had two Norco unaccounted for. Resident
#4 had 11 Percocet unaccounted for. Resident #5 had one dose tramadol 50 mg unaccounted for. Resident
#6 had one dose of tramadol unaccounted for. The DON also stated agency staff were not being used at
this time. If the facility needed to use agency staff in the future, the nurse's licenses would be checked by
the facility before the nurse could cover a shift.
The Inventory Control of Controlled Substances policy and procedure revised on 08/01/24 revealed the
facility should ensure incoming and outgoing nurses count all Schedule II controlled substances and other
medications with a risk of abuse of diversion at the change of each shift and document the results on a
Controlled Substance Count Verification/Shift Count Sheet. The total number of controlled medications on
hand and number of doses remaining in the packages should be reconciled. The facility should ensure its
staff immediately report suspected theft or loss of controlled substances to their supervisor/manager. The
facility should ensure the appropriate facility personnel confirm the discrepancy and follow facility policy and
applicable law regarding documentation of the incident.
The Abuse, Neglect and Exploitation policy revised 07/11/24 revealed misappropriation is the deliberate
misplacement, exploitation, or wrongful, temporary, or permanent use of resident's belongings or money
without the resident's consent. If the facility enters into a contract for the use of temporary (agency)
employees, then it will generally require the organization providing such employees to conduct the
background checks and to certify that it will not provide any temporary employees that do not have the
requisite licensure or certification.
The deficiency was corrected on 11/28/24 when the facility implemented the following corrective actions:
•
On 11/27/24 the DON completed narcotic accountability records and narcotic counts on all medication
carts.
•
On 11/27/24 Residents #1, #2, #3, #4, and #6 were interviewed about pain management and updated pain
observations were completed by DON/Licensed Nurse. Resident #5 was at the hospital on [DATE].
•
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366253
If continuation sheet
Page 3 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366253
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/20/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Amberwood Manor
245 South Broadway
New Philadelphia, OH 44663
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0602
On 11/27/24 head-to-toe observations were completed by DON/Licensed Nurse for Residents #1, #2, #3,
#4, and #6 to ensure there was no physical abuse.
Level of Harm - Minimal harm
or potential for actual harm
•
Residents Affected - Some
On 11/27/24 the attending physician/medical director were notified by the DON of potential drug diversion.
•
On 11/27/24 the Licensed Nursing Home Administrator (LNHA) initiated a SRI to the Ohio Department of
Health.
•
On 11/27/24 the LNHA made phone calls to RN #103 and the agency company.
•
On 11/27/24 the DON spoke with the agency company and requested RN #103 have a drug screen
completed.
•
On 11/27/24 the LNHA reviewed random employee files for two LPN's and three RNs, and no negative
findings were discovered.
•
On 11/27/24 the DON contacted the local police department.
•
On 11/27/24 the DON sent an email to Consultant Pharmacist about the allegation of misappropriation of
narcotic mediation.
•
On 11/27/24 the 27 residents that were able to be interviewed were interviewed about pain management
and medication being administered. No negative findings were discovered.
•
On 11/27/24 the 14 residents that were not able to be interviewed had head-to-toe skin observations
completed. No negative findings were discovered.
•
On 11/27/24 all 41 residents had pain assessments completed by a licensed nurse.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366253
If continuation sheet
Page 4 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366253
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/20/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Amberwood Manor
245 South Broadway
New Philadelphia, OH 44663
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0602
•
Level of Harm - Minimal harm
or potential for actual harm
On 11/27/24 the LNHA and DON educated all 54 staff on Abuse, Neglect, and Misappropriation.
•
Residents Affected - Some
On 11/27/24 the DON/designee educated all 12 licensed nurses (five LPN's and seven RN's) on Drug
Diversion and narcotic accountability.
•
On 11/27/24 an in-service for nurses revealed the nurse was to look at the card of controlled medication
and the narcotic accountability sheet when narcotics were being counted at shift change.
•
On 11/27/24 an ad hoc Quality Assurance and Performance Improvement (QAPI) meeting was held with
the medical director in attendance.
•
The DON/designee will complete a narcotic count on each medication cart three times a week for four
weeks and then monthly for two months.
•
The DON/designee will audit completed narcotic accountability records three times a week for four weeks
and then monthly for two months to ensure any as needed controlled medications administered are
documented properly on the MAR and the resident validates (if able) the receipt of the medication.
This deficiency represents non-compliance investigated under Self-Reported Incident, Control Number
OH00160410.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366253
If continuation sheet
Page 5 of 5